feed,title,long_url,short_url
Benzinga,Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021,https://benzinga.com/pressreleases/21/02/g19850003/clene-nanomedicine-presents-updated-interim-data-from-phase-2-multiple-sclerosis-programs-at-actri,
Benzinga,"Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call on March 3, 2021",https://benzinga.com/pressreleases/21/02/g19849956/strongbridge-biopharma-plc-to-host-fourth-quarter-and-full-year-2020-financial-results-conference-,
Benzinga,"Vinergy Appoints Albert Szmigielski, a Blockchain and Digital Currency Expert, as an Advisor to the Investment Committee",https://benzinga.com/pressreleases/21/02/g19849954/vinergy-appoints-albert-szmigielski-a-blockchain-and-digital-currency-expert-as-an-advisor-to-the-,
Benzinga,Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical Officer,https://benzinga.com/pressreleases/21/02/g19849953/spark-therapeutics-further-strengthens-technical-expertise-with-appointment-of-cynthia-pussinen-as,
Benzinga,Aleafia Health to Announce 2020 Fourth Quarter and Year End Results,https://benzinga.com/pressreleases/21/02/g19849942/aleafia-health-to-announce-2020-fourth-quarter-and-year-end-results,
Benzinga,22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results,https://benzinga.com/pressreleases/21/02/g19849941/22nd-century-group-to-host-webcast-to-discuss-fourth-quarter-and-full-year-2020-results,
Benzinga,Otonomy to Participate in Three Upcoming Investor Conferences,https://benzinga.com/pressreleases/21/02/g19849939/otonomy-to-participate-in-three-upcoming-investor-conferences,
Benzinga,Plus Products Inc. Announces Debentureholder Approval of Debenture Amendments,https://benzinga.com/pressreleases/21/02/g19849951/plus-products-inc-announces-debentureholder-approval-of-debenture-amendments,
